Evidence map›Paper›PMID 35340018›Full record

ArticleScientific reports2022

Alteration of barrier properties, stratum corneum ceramides and microbiome composition in response to lotion application on cosmetic dry skin.

Barry Murphy, Sally Grimshaw, Michael Hoptroff, Sarah Paterson, David Arnold, Andrew Cawley, Suzanne E Adams, Francesco Falciani, Tony Dadd, Richard Eccles and 9 more

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2026
    Review
  7. Pharmaceutical biology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Enhancing Transcutaneous Drug Delivery: Advanced Perspectives on Skin Models.JID innovations : skin science from molecules to population health · 2025
    Review
  13. Article
  14. Antiaging Properties ofMolecules (Basel, Switzerland) · 2024
    Article
  15. Article
  16. Review
  17. Review
  18. The inner elbow skin microbiome containsMicrobiome research reports · 2024
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Barry MurphyUnilever Research & Development, Port Sunlight, Bebington, Wirral, CH63 3JW, England, UK. Barry.murphy@unilever.com.ORCID 0000-0003-2305-5875
Sally GrimshawUnilever Research & Development, Port Sunlight, Bebington, Wirral, CH63 3JW, England, UK.ORCID 0000-0002-7033-9291
Michael HoptroffUnilever Research & Development, Port Sunlight, Bebington, Wirral, CH63 3JW, England, UK.ORCID 0000-0003-4437-6221
Sarah PatersonUnilever Research & Development, Port Sunlight, Bebington, Wirral, CH63 3JW, England, UK.ORCID 0000-0002-6512-1888
David ArnoldUnilever Research & Development, Port Sunlight, Bebington, Wirral, CH63 3JW, England, UK.ORCID 0000-0003-1269-4516
Andrew CawleyUnilever Research & Development, Port Sunlight, Bebington, Wirral, CH63 3JW, England, UK.ORCID 0000-0002-3426-0850
Suzanne E AdamsUnilever Research & Development, Port Sunlight, Bebington, Wirral, CH63 3JW, England, UK.ORCID 0000-0001-9617-6374
Francesco FalcianiInstitute of Infection, Veterinary, and Ecological Sciences, University of Liverpool, Liverpool, L69 7ZB, England, UK.ORCID 0000-0003-1432-2871
Tony DaddUnilever Research & Development, Colworth, Bedfordshire, MK44 1LQ, England, UK.ORCID 0000-0003-4523-9595
Richard EcclesInstitute of Infection, Veterinary, and Ecological Sciences, University of Liverpool, Liverpool, L69 7ZB, England, UK.ORCID 0000-0001-7210-6689
Alex MitchellEagle Genomics, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1DR, UK.ORCID 0000-0001-8655-7966
William F LathropUnilever Research & Development, 55 Merritt Blvd, Trumbull, CT, 06611, USA.ORCID 0000-0001-6434-3975
Diana MarreroUnilever Research & Development, 55 Merritt Blvd, Trumbull, CT, 06611, USA.ORCID 0000-0003-3261-6208
Galina YarovaUnilever Research & Development, 55 Merritt Blvd, Trumbull, CT, 06611, USA.ORCID 0000-0002-4105-1504
Ana VillaUnilever Research & Development, 55 Merritt Blvd, Trumbull, CT, 06611, USA.ORCID 0000-0002-4025-9506
John S BajorUnilever Research & Development, 55 Merritt Blvd, Trumbull, CT, 06611, USA.ORCID 0000-0003-4614-6956
Lin FengUnilever Research & Development, 55 Merritt Blvd, Trumbull, CT, 06611, USA.ORCID 0000-0001-9124-1544
Dawn MihalovUnilever Research & Development, 55 Merritt Blvd, Trumbull, CT, 06611, USA.ORCID 0000-0001-9408-0643
Andrew E MayesUnilever Research & Development, Colworth, Bedfordshire, MK44 1LQ, England, UK.ORCID 0000-0003-4060-0660

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xerosis, commonly referred to as dry skin, is a common dermatological condition affecting almost a third of the population. Successful treatment of the condition traditionally involves the application of cosmetic products facilitating the moisturisation of the skin with a range of ingredients including glycerol and fatty acids. While the effectiveness of these treatments is not in question, limited information exists on the impact on the skin microbiome following use of these products and the improvement in skin hydration. Here, we describe improvements in skin barrier properties together with increased levels of cholesterol, ceramides and long-chain fatty acids following application of Body Lotion. Concomitant alterations in the skin microbiome are also seen via 16S rRNA metataxonomics, in combination with both traditional and novel informatics analysis. Following 5 weeks of lotion use, beneficial skin bacteria are increased, with improvements in microbiome functional potential, and increases in pathways associated with biosynthesis of multiple long chain fatty acids.

Indexed as

CeramidesMicrobiotaEpidermisRNA, Ribosomal, 16SSkinCeramidesRNA, Ribosomal, 16S

Identifiers

PMID35340018
PMCPMC8957616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.